Choosing a GLP-1R agonist is mostly based on what the patient wants
intra-articular injection dosing for joint conditions is determined by the administering physician Frequency Once daily, or divided into two doses for higher-dose subcutaneous protocols Administration Subcutaneous injection near the injury site (musculoskeletal and systemic)
Nausea Diarrhea Vomiting Constipation Abdominal discomfort These effects are most likely to occur when increasing dosages, and often improve over time as the body adjusts
After reconstitution, it is stable at 4C for 1 week or -20C for longer (with carrier protein)
People who are pregnant or breastfeeding, or who are managing active cancer or other serious conditions, should not start these peptides without specialist guidance
The medicine can be injected under the skin of the abdomen, thigh or upper arm